Newsroom

Verantos and Amgen publish on AI in asthma

Publications

Given that each patient’s asthma journey and disease severity are influenced by a complex constellation of factors, AI-based approaches are ideally suited to identify asthma outcomes when the proper inputs are provided and especially when the real-world data used to develop these models are enhanced with unstructured electronic health record data. This manuscript summarizes efforts to use AI to predict exacerbations, ED visits, and admissions — all clinically relevant endpoints in asthma real-world evidence.

Read at the original outlet
All news
Get started

Ready to advance your evidence program?

Speak with our team about how the Verantos pharmacoepidemiology stack can accelerate your timeline.